Old Mission Capital LLC Incannex Healthcare LTD Transaction History

Old Mission Capital LLC

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$2.72 - $4.76 $55,942 - $97,898
20,567 New
20,567 $57,000
Q2 2022

Aug 05, 2022
SELL
$3.86 - $9.14 $38,600 - $91,400
-10,000 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$9.16 - $35.5 $91,600 - $355,000
10,000 New
10,000 $92,000

About Incannex Healthcare Ltd

IXHL Quotes by TradingView
  • Ticker IXHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 51,693,400
  • Market Cap $94.1M
  • Description
  • Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury...
More about IXHL
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email